Safety, pharmacokinetics, and pharmacodynamics of single doses of an oral p38 MAP kinase inhibitor (BIRB 796 BS) in healthy human males a placebo-controlled, randomised study, double blinded at each dose level
2002 ◽
Vol 109
(1)
◽
pp. S67-S67
◽
Keyword(s):
2002 ◽
Vol 109
(1)
◽
pp. S321-S321
Keyword(s):
2005 ◽
Vol 98
(1)
◽
pp. 77-82
◽
Keyword(s):
2000 ◽
Vol 278
(3)
◽
pp. G429-G437
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 220
◽
pp. 109994
Keyword(s):
2009 ◽
Vol 297
(5)
◽
pp. G878-G885
◽